Duncan Moore - Net Worth and Insider Trading

Duncan Moore Net Worth

The estimated net worth of Duncan Moore is at least $4 Million dollars as of 2024-05-23. Duncan Moore is the Director of ASP Isotopes Inc and owns about 854,167 shares of ASP Isotopes Inc (ASPI) stock worth over $4 Million. Details can be seen in Duncan Moore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Duncan Moore has not made any transactions after 2023-10-26 and currently still holds the listed stock(s).

Transaction Summary of Duncan Moore

To

Duncan Moore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Duncan Moore owns 2 companies in total, including Allarity Therapeutics Inc (ALLR) , and ASP Isotopes Inc (ASPI) .

Click here to see the complete history of Duncan Moore’s form 4 insider trades.

Insider Ownership Summary of Duncan Moore

Ticker Comapny Transaction Date Type of Owner
ALLR Allarity Therapeutics Inc 2021-12-20 director
ASPI ASP Isotopes Inc 2023-10-26 director

Duncan Moore Latest Holdings Summary

Duncan Moore currently owns a total of 1 stock. Duncan Moore owns 854,167 shares of ASP Isotopes Inc (ASPI) as of October 26, 2023, with a value of $4 Million.

Latest Holdings of Duncan Moore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ASPI ASP Isotopes Inc 2023-10-26 854,167 5.03 4,296,460

Holding Weightings of Duncan Moore


Duncan Moore Form 4 Trading Tracker

According to the SEC Form 4 filings, Duncan Moore has made a total of 3 transactions in ASP Isotopes Inc (ASPI) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in ASP Isotopes Inc is the acquisition of 104,167 shares on October 26, 2023, which cost Duncan Moore around $100,000.

Insider Trading History of Duncan Moore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Duncan Moore Trading Performance

GuruFocus tracks the stock performance after each of Duncan Moore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Duncan Moore is 65.73%. GuruFocus also compares Duncan Moore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Duncan Moore within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Duncan Moore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Duncan Moore

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 54.97
Relative Return to S&P 500(%) 49.9

Duncan Moore Ownership Network

Ownership Network List of Duncan Moore

No Data

Ownership Network Relation of Duncan Moore


Duncan Moore Owned Company Details

What does Allarity Therapeutics Inc do?

Who are the key executives at Allarity Therapeutics Inc?

Duncan Moore is the director of Allarity Therapeutics Inc. Other key executives at Allarity Therapeutics Inc include Chief Financial Officer Joan Yvonne Brown , director & Chief Executive Officer Steve Carchedi , and Chief Scientific Officer Steen Knudsen .

Allarity Therapeutics Inc (ALLR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Allarity Therapeutics Inc (ALLR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allarity Therapeutics Inc (ALLR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allarity Therapeutics Inc (ALLR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allarity Therapeutics Inc Insider Transactions

No Available Data

Duncan Moore Mailing Address

Above is the net worth, insider trading, and ownership report for Duncan Moore. You might contact Duncan Moore via mailing address: C/o Asp Isotopes Inc., 433 Plaza Real, Suite 275, Boca Raton Fl 33432.

Discussions on Duncan Moore

No discussions yet.